{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:32:30Z","timestamp":1792272750518,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Neurosurg Jl"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>IgG4-related hypertrophic pachymeningitis is a relative newly recognized and rare manifestation of IgG4-related disease, an immune-mediated fibroinflammatory tumefactive disorder. Fewer than 80 patients have been reported in the literature, and it can mimic common neurosurgical conditions. We describe the clinical presentation of two patients that were initially considered to have a subdural collection, tuberculous meningitis, and a cervical spinal meningioma, but were eventually diagnosed with this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Two ethnic Chinese men, 86 and 62 years old, experienced a 4-week history of headache. Both patients had a history of autoimmune disease, namely glomerulonephritis and Grave\u2019s disease, respectively. Magnetic resonance brain imaging revealed diffuse dural thickening with the latter patient exhibiting homogeneous and intense gadolinium-contrast enhancement. Since the 86-year-old patient also had progressive bilateral visual loss, giant cell arteritis was suspected and a 2-week course of glucocorticoid therapy was prescribed, but his symptoms failed to improve. The 62-year-old patient also had accompanying low-grade fever and was treated empirically as having tuberculous meningitis although there were no confirmatory microbiological findings. This patient further developed right hemiparesis, and additional imaging revealed a C4\/5 intradural-extramedullary contrast-enhancing lesion resembling a meningioma causing cord compression. Both patients underwent neurosurgical intervention with the former undergoing a dural biopsy and the latter having the cervical lesion resected. The final diagnosis was IgG4-related hypertrophic pachymeningitis with the hallmark histological features of lymphoplasmacytic infiltration of IgG4+ plasma cells, storiform fibrosis, and obliterative phlebitis. In addition, their serum IgG4 levels were elevated (i.e., &gt; 135 mg\/dL). Both patients received at least 6 months of glucocorticoid therapy while the latter also had azathioprine. Their symptoms improved significantly and recurrent lesions were not detected on follow-up imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A high index of suspicion for this condition is suggested when a male patient with a history of autoimmune disease and compatible radiological findings, experiences subacute headache that is disproportionate to the degree of dural involvement. Neurosurgeons should consider early meningeal biopsy to establish a definitive histological diagnosis in order for early effective immunosuppressive treatment to be initiated and to avoid unnecessary morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41016-021-00233-5","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T20:02:15Z","timestamp":1612382535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: a report of two cases"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-7904","authenticated-orcid":false,"given":"Peter Y. M.","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben C. F.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June H. M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver K. S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S. K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngai-Fung","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwong-Yau","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"233_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/cei.12641","volume":"181","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181:191\u2013206.","journal-title":"Clin Exp Immunol."},{"key":"233_CR2","doi-asserted-by":"publisher","first-page":"e4002","DOI":"10.1097\/MD.0000000000004002","volume":"95","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016;95:e4002.","journal-title":"Medicine (Baltimore)"},{"key":"233_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11940-017-0450-9","volume":"19","author":"B Baptista","year":"2017","unstructured":"Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM. Neurological manifestations of IgG4-related disease. Curr Treat Options Neurol. 2017;19:14.","journal-title":"Curr Treat Options Neurol."},{"key":"233_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","volume":"85","author":"T Yonekawa","year":"2014","unstructured":"Yonekawa T, Murai H, Utsuki S, Matsushita T, Masaki K, Isobe N, et al. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 2014;85:732\u20139.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"233_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/PAS.0b013e3181abdfc2","volume":"33","author":"SK Chan","year":"2009","unstructured":"Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009;33:1249\u201352.","journal-title":"Am J Surg Pathol."},{"key":"233_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","volume":"92","author":"ZS Wallace","year":"2013","unstructured":"Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, et al. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013;92:206\u201316.","journal-title":"Medicine (Baltimore)"},{"key":"233_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","volume":"71","author":"LX Lu","year":"2014","unstructured":"Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014;71:785\u201393.","journal-title":"JAMA Neurol."},{"key":"233_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3171\/2016.4.SPINE1674","volume":"25","author":"BD Radotra","year":"2016","unstructured":"Radotra BD, Aggarwal A, Kapoor A, Singla N, Chatterjee D. An orphan disease: IgG4-related spinal pachymeningitis: report of 2 cases. J Neurosurg Spine. 2016;25:790\u20134.","journal-title":"J Neurosurg Spine."},{"issue":"Suppl 1","key":"233_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00586-015-4251-0","volume":"25","author":"R Gu","year":"2016","unstructured":"Gu R, Hao PY, Liu JB, Wang ZH, Zhu QS. Cervicothoracic spinal cord compression caused by IgG4-related sclerosing pachymeningitis: a case report and literature review. Eur Spine J. 2016;25(Suppl 1):147\u201351.","journal-title":"Eur Spine J."},{"key":"233_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","volume":"23","author":"A Nirula","year":"2011","unstructured":"Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23:119\u201324.","journal-title":"Curr Opin Rheumatol."},{"key":"233_CR11","first-page":"795","volume":"63","author":"H Miyazaki","year":"2011","unstructured":"Miyazaki H, Tabuse M, Ishiyama N, Kikuchi R, Ogihara T, Nanki K. A case of multifocal fibrosclerosis presenting with chronic subdural hematoma. Brain Nerve. 2011;63:795\u20139.","journal-title":"Brain Nerve."},{"key":"233_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nec.2015.11.010","volume":"27","author":"VM Ravindra","year":"2016","unstructured":"Ravindra VM, Schmidt MH. Management of spinal meningiomas. Neurosurg Clin N Am. 2016;27:195\u2013205.","journal-title":"Neurosurg Clin N Am."},{"key":"233_CR13","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3174\/ajnr.A3147","volume":"33","author":"K Toyoda","year":"2012","unstructured":"Toyoda K, Oba H, Kutomi K, Furui S, Oohara A, Mori H, et al. MR imaging of IgG4-related disease in the head and neck and brain. AJNR Am J Neuroradiol. 2012;33:2136\u20139.","journal-title":"AJNR Am J Neuroradiol."},{"key":"233_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u201392.","journal-title":"Mod Pathol."},{"key":"233_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00401-010-0746-2","volume":"120","author":"KM Lindstrom","year":"2010","unstructured":"Lindstrom KM, Cousar JB, Lopes MB. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010;120:765\u201376.","journal-title":"Acta Neuropathol."},{"key":"233_CR16","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755\u201362.","journal-title":"Arthritis Rheum."},{"key":"233_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/jnnp-2017-316519","volume":"89","author":"E Della-Torre","year":"2018","unstructured":"Della-Torre E, Campochiaro C, Cassione EB, Albano L, Gerevini S, Bianchi-Marzoli S, et al. Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis. J Neurol Neurosurg Psychiatry. 2018;89:441\u20134.","journal-title":"J Neurol Neurosurg Psychiatry."}],"container-title":["Chinese Neurosurgical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-021-00233-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41016-021-00233-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-021-00233-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T20:02:18Z","timestamp":1612382538000},"score":1,"resource":{"primary":{"URL":"https:\/\/cnjournal.biomedcentral.com\/articles\/10.1186\/s41016-021-00233-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1186\/s41016-021-00233-5","relation":{},"ISSN":["2057-4967"],"issn-type":[{"value":"2057-4967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"1 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}